Stock Earnings

Question 1

How did HALO's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Halozyme Therapeutics Inc is $-0.24, not beating expectations of $2.24.

Question 2

How did Halozyme Therapeutics Inc HALO's revenue perform in the last quarter?

Accepted Answer

Halozyme Therapeutics Inc revenue for the last quarter is $-0.24

Question 3

What is the revenue estimate for Halozyme Therapeutics Inc?

Accepted Answer

According to 8 of Wall street analyst, the revenue estimate of Halozyme Therapeutics Inc range from $435.75M to $374.16M

Question 4

What's the earning quality score for Halozyme Therapeutics Inc?

Accepted Answer

Halozyme Therapeutics Inc has a earning quality score of B+/53.7299. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Halozyme Therapeutics Inc report earnings?

Accepted Answer

Halozyme Therapeutics Inc next earnings report is expected in 2026-05-18

Question 6

What are Halozyme Therapeutics Inc's expected earnings?

Accepted Answer

Halozyme Therapeutics Inc expected earnings is $446.73M, according to wall-street analysts.

Question 7

Did Halozyme Therapeutics Inc beat earnings expectations?

Accepted Answer

Halozyme Therapeutics Inc recent earnings of $451.76M beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$2.24	$-0.24	-110.71%	MISSED
Q3 '25	$1.66	$1.72	+3.61%	BEAT
Q2 '25	$1.29	$1.54	+19.37%	BEAT
Q1 '25	$0.96	$1.11	+15.62%	BEAT
Q4 '24	$1.18	$1.26	+6.77%	BEAT

Halozyme Therapeutics Inc (HALO) Earnings

HALO Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is HALO?